Shell is moving closer to a major reshaping of its chemicals business, with ExxonMobil, LyondellBasell, Apollo Global Management and the chemicals arm of Kuwait Petroleum Corporation among the potential buyers interested in its US assets.
The assets could fetch as much as $8 billion, according to people familiar with the matter cited by the Financial Times. Potential buyers submitted non-binding offers last month, with proposals ranging from purchasing the entire portfolio to acquiring individual assets. There is no guarantee that a transaction will ultimately be completed.
For Shell, the potential sale is about more than raising cash. It represents another step in Chief Executive Officer Wael Sawan’s effort to simplify the company, dispose of underperforming businesses and concentrate capital on areas where Shell believes it can generate stronger returns.
The potential transaction also highlights a broader shift in the global energy industry: while Shell is reducing its exposure to chemicals, other major oil companies are becoming more interested in the sector because chemicals could become increasingly important as demand for traditional transportation fuels changes.
ExxonMobil and LyondellBasell Lead the Potential Buyer List
The list of interested parties includes some of the biggest names in the global chemicals industry.
ExxonMobil has expressed interest, as has LyondellBasell. Private-equity firm Apollo Global Management is also considering the assets, while the chemicals division of Kuwait Petroleum Corporation has reportedly shown interest.
The variety of potential buyers is significant.
Exxon could use the assets to strengthen its integrated chemicals operations.
LyondellBasell is already a major global plastics and chemicals producer, meaning the Shell facilities could provide operational and strategic synergies.
Apollo would approach the assets differently, potentially looking for opportunities to improve operations, restructure the portfolio or sell individual businesses in the future.
Kuwait Petroleum, meanwhile, could use the acquisition to expand its position further along the energy value chain.
The Assets Are Spread Across Several US Locations
Shell’s US chemicals portfolio includes four sites across Louisiana, Texas and Pennsylvania.
The facilities produce chemicals used in a wide range of products, including plastics, detergents and pharmaceuticals.
The most notable asset is Shell’s Monaca complex in Pennsylvania.
The facility began operations in 2022 following an enormous investment of approximately $14 billion.
It has the capacity to produce as much as 1.6 million tonnes of polymers annually.
That makes the potential sale price particularly striking.
If the entire portfolio ultimately sells for around $8 billion, Shell could receive substantially less than the capital it invested in the facilities.
An $8 Billion Sale Would Represent a Major Discount
The potential valuation is one of the most important aspects of the story.
Shell invested heavily in its US chemicals operations, particularly the Monaca facility.
Yet the assets could now be worth only around $8 billion collectively.
That gap demonstrates how quickly industrial asset values can change when market conditions deteriorate.
Building a large chemicals facility is enormously expensive.
But replacement cost does not necessarily determine market value.
Buyers care about future cash flow.
If margins are weak and the outlook uncertain, even a recently constructed facility can be worth far less than the amount originally spent to build it.
Why Shell Wants Out of Chemicals
Shell has increasingly questioned whether chemicals should remain a core part of its portfolio.
Sawan has said the company has deployed around $45 billion of capital into businesses that have underperformed, with chemicals and renewable energy among the areas contributing to that figure.
That is a major warning sign.
Shell is not simply selling one unwanted facility.
It is reassessing whether entire categories of investment fit its future strategy.
The company said last year that it did not view itself as the “natural owner” of its chemicals portfolio and wanted to reduce its exposure by 2030.
Chemicals Have Been a Difficult Business
The chemicals industry has faced challenging market conditions.
Producers have had to contend with weak margins, excess capacity and changing demand patterns.
Shell’s chemicals unit had been loss-making for an extended period before conditions improved more recently.
That creates a difficult decision for management.
If the market is near the bottom of the cycle, selling assets can lock in poor returns.
But waiting for a recovery carries its own risk.
The company has previously indicated that it wanted to be patient rather than sell at the worst possible point in the cycle.
The current bidding process suggests Shell believes it has enough interest from potential buyers to seriously evaluate an exit.
Why Buyers Still Want the Assets
The fact that several companies are interested despite Shell’s difficulties tells us something important.
A bad asset for one owner can be a good asset for another.
ExxonMobil or LyondellBasell may be able to generate better economics through integration.
They could potentially combine Shell’s plants with existing feedstock, distribution networks and manufacturing operations.
That could lower costs and improve margins.
A private-equity buyer such as Apollo could pursue a different strategy by restructuring the portfolio and focusing investment on the most profitable facilities.
The value therefore depends partly on who owns the assets.
Exxon Has a Strategic Reason to Look
ExxonMobil has been expanding its presence across the petrochemical value chain.
The company sees chemicals as an important long-term business because hydrocarbons can be converted into materials even as their use as transportation fuels gradually changes.
For Exxon, acquiring Shell’s facilities could strengthen an existing business rather than create an entirely new one.
That potential strategic fit makes Exxon one of the more logical buyers.
But Exxon would still need to determine whether the assets can produce acceptable returns at the current market valuation.
LyondellBasell Could Also Find Synergies
LyondellBasell has extensive experience in polymers and chemicals.
That could make Shell’s US facilities particularly attractive.
The company could potentially combine Shell’s production with its own operations and distribution channels.
Acquiring an existing facility can also be faster than building new capacity from scratch.
However, the same problem remains.
Additional capacity is useful only if demand and margins justify it.
A buyer cannot create profitability simply by owning more plants.
Apollo Brings a Different Strategy
Apollo Global Management would bring a private-equity approach to the transaction.
Private-equity firms typically focus heavily on cash flow, cost structures, asset values and potential exit opportunities.
Apollo could potentially acquire all or part of the portfolio and later sell individual assets.
That makes the bidding process more interesting.
Strategic buyers and financial buyers may value the same assets very differently.
A strategic buyer may pay more because of synergies.
A financial buyer may demand a lower price because it needs a clear path to future returns.
Kuwait Petroleum Could Strengthen Its Downstream Position
Kuwait Petroleum’s chemicals division is another potential buyer.
For a major oil-producing country, chemicals provide a way to extend the value of crude oil beyond traditional fuel markets.
Oil can be transformed into petrochemical feedstocks and ultimately into plastics and other industrial products.
That makes chemicals strategically attractive for national oil companies.
Kuwait is not alone in pursuing this strategy.
Saudi Aramco and other Gulf energy companies have also been increasing their interest in chemicals.
The Bigger Industry Shift Is Important
The Shell sale highlights a contradiction within the oil industry.
Some companies are reducing their exposure to chemicals.
Others are increasing it.
The difference comes down to strategy.
Shell is prioritizing upstream oil and gas production and trading, areas where management believes it can achieve stronger returns.
Other oil companies believe chemicals will become more important as the global transportation system becomes less dependent on petroleum fuels.
Both strategies can be rational.
The outcome will depend on how quickly energy demand changes and how profitable chemicals become.
Road-Fuel Demand Could Change the Equation
Electric vehicles are expected to reduce demand for gasoline and other road fuels over time.
That creates a long-term challenge for oil producers.
But chemicals are different.
Plastics, packaging, industrial materials, pharmaceuticals and other products continue to require petrochemical feedstocks.
If transportation consumes less oil while chemical demand remains strong, a greater proportion of future oil demand could come from petrochemicals.
That is one reason companies such as Saudi Aramco and other large energy producers are investing heavily in integrated chemical operations.
Shell Is Moving in the Opposite Direction
Shell’s strategy is becoming increasingly clear.
The company wants fewer businesses, stronger returns and greater concentration on its most profitable activities.
The potential chemicals sale follows other portfolio changes.
Earlier this month, Shell agreed to sell its European onshore renewable power business to TotalEnergies.
The pattern is difficult to miss.
Shell is reducing exposure to businesses that management believes are generating inadequate returns and directing resources toward oil, gas and trading.
The ARC Resources Acquisition Shows Where Shell Wants to Go
Shell’s strategy is also visible through acquisitions.
Earlier this year, the company agreed to acquire Canadian shale producer ARC Resources for $16.4 billion, its largest acquisition in roughly a decade.
That is a striking contrast.
Shell is potentially selling chemicals assets for around $8 billion while pursuing a multibillion-dollar acquisition in upstream oil and gas.
The message to investors is straightforward:
Shell would rather deploy capital into businesses it believes can generate higher returns than continue funding underperforming chemicals operations.
Shell Is Not Selling at Any Price
The company still faces an important decision.
Management has previously indicated that it does not want to sell assets at the bottom of the market.
That means the bidding process could potentially fail if offers are too low.
There is a difference between wanting to exit a business and being willing to accept any price for it.
Shell has strong financial resources and does not appear to be under immediate pressure to sell simply to raise cash.
That gives it negotiating flexibility.
Non-Binding Offers Mean the Deal Is Far From Done
Investors should not treat the reported $8 billion valuation as a completed transaction.
The offers submitted so far are reportedly non-binding.
Potential buyers could revise their bids.
Shell could reject the offers.
A buyer could withdraw.
The company could also decide to sell the portfolio in pieces rather than to a single purchaser.
That means the eventual transaction value could be substantially different from the currently reported figure.
A Partial Sale Could Make More Sense
One possibility is that Shell sells only certain facilities.
Some plants may be more attractive because they have better economics, newer equipment or stronger local markets.
Others may be less attractive because of high operating costs or weaker demand.
Selling the portfolio in pieces could allow Shell to maximize value.
But it could also make the process more complicated.
A buyer interested in the entire business may prefer to purchase all the assets together.
The Monaca Facility Is the Biggest Question
The Pennsylvania complex deserves particular attention.
Shell spent around $14 billion building the facility, and it only began operating in 2022.
Selling it for a fraction of the investment would represent a painful outcome.
But the original investment is now a sunk cost.
The relevant question is not what Shell spent.
It is what the facility can generate from this point forward.
That distinction is critical for management.
Continuing to own an underperforming asset simply because it was expensive to build can destroy even more value.
What Buyers Will Be Looking At
Potential buyers will likely examine several factors.
Production economics
How much does each facility cost to operate?
Feedstock access
Can the plants secure competitive raw materials?
Product demand
How strong is demand for the chemicals and polymers being produced?
Infrastructure
How efficiently can products reach customers?
Future margins
Could chemicals profitability improve as market conditions normalize?
Capital requirements
How much additional investment will the facilities need?
Environmental liabilities
What future regulatory and cleanup obligations could come with the assets?
These factors could determine the final price far more than the headline $8 billion figure.
Shell’s Portfolio Strategy Is Becoming More Aggressive
Sawan has increasingly emphasized capital discipline.
The company’s second-quarter 2026 results showed strong financial performance, while Shell said it was continuing to simplify the portfolio and strengthen its balance sheet.
Shell reported that it reduced net debt to around $42 billion, or approximately $12 billion excluding leases, and announced another $3 billion share-buyback program.
That suggests the company has room to be selective.
It does not need to sell chemicals simply to survive.
It can sell if management believes another owner can create more value from the assets.
The Sale Could Improve Shell’s Investor Story
For shareholders, the potential chemicals divestment could strengthen Shell’s investment narrative.
A smaller company focused on upstream operations and trading may be easier to understand.
Investors can more clearly evaluate where capital is being deployed.
Removing underperforming businesses could also improve returns on capital.
But there is a counterargument.
Chemicals could eventually become more valuable as global oil demand shifts.
Selling now could mean giving up exposure to a sector that later recovers.
That is the central strategic gamble.
Shell Is Betting on Higher Returns Elsewhere
The company appears willing to accept that risk.
Shell’s management is effectively saying that owning a potentially attractive long-term chemicals business is less important than generating strong returns today.
That is a different philosophy from some competitors.
Chevron, Saudi Aramco and other major energy companies are positioning themselves to capture more of the petrochemical value chain.
Shell is narrowing its focus.
Only time will determine which strategy proves more successful.
The Potential Deal Matters Beyond Shell
The transaction could have wider consequences for the US chemicals industry.
If Exxon or LyondellBasell wins, industry consolidation could increase.
Fewer companies controlling large amounts of production can change competitive dynamics.
If Apollo wins, the assets could eventually be reorganized or sold to multiple strategic buyers.
If Kuwait Petroleum acquires the facilities, it would represent another example of Gulf energy capital expanding into US industrial infrastructure.
The outcome therefore matters to competitors, customers and investors across the chemicals market.
Conclusion
Shell’s US chemicals portfolio has attracted interest from ExxonMobil, LyondellBasell, Apollo Global Management and Kuwait Petroleum Corporation’s chemicals arm, with the assets potentially valued at up to $8 billion. The interested parties reportedly submitted non-binding offers last month, meaning the sale process remains preliminary.
The potential transaction is significant because Shell invested billions of dollars building and expanding its chemicals operations, including approximately $14 billion in the Monaca facility in Pennsylvania.
Selling the portfolio for a fraction of that investment would be painful.
But the decision is not really about recovering historical spending.
It is about deciding where Shell can earn the best returns in the future.
Under Sawan, Shell has been aggressively simplifying its portfolio and shifting capital toward upstream oil and gas and trading. The potential chemicals sale, alongside the disposal of its European renewable power business and the major ARC Resources acquisition, reinforces that strategy.
For potential buyers, however, Shell’s retreat could represent an opportunity.
Exxon and LyondellBasell could potentially create synergies from the assets. Apollo could restructure them. Kuwait Petroleum could use them to expand its downstream and chemicals footprint.
The biggest question is whether the chemicals market eventually recovers enough to justify today’s investment.
Shell appears willing to let another company take that bet.
For Shell, the message is increasingly clear: owning more assets is not the objective. Owning assets that generate attractive returns is.
